WHO Allocates $1.5 Billion in Aid, Global Primary Health Care Systems Face Major Challenges!
On 23 September 2024, the World Health Organization (WHO) announced a major collaboration with the world's multilateral development banks to build a massive primary health financing platform totaling $1.5 billion. This initiative not only demonstrates WHO's leadership in the cause of global health, but also demonstrates the international community's great importance and firm determination to raise the level of global primary health care.
In an official statement, WHO elaborated on the significance of this financing platform. They pointed out that primary health care is the foundation of the medical system and plays an irreplaceable role in promoting the health of the whole people, preventing diseases and reducing the medical burden. However, in many developing countries, due to limited economic conditions and lack of medical resources, the construction and operation of primary health care systems face great challenges. Therefore, WHO has decided to provide the necessary financial and technical assistance to those countries and regions that need it most through this financing platform.
The first investments will cover 15 countries worldwide, including developing countries such as Burundi, Ethiopia, Jordan and the Maldives. These countries generally face problems such as insufficient medical resources, backward infrastructure, and weak disease prevention and control capabilities, and the construction of primary health care systems is particularly urgent. The WHO said that they will develop personalized investment plans based on the actual situation and needs of countries to ensure that funds are targeted to where they are most needed.
In order to ensure the effective use of funds and the smooth implementation of projects, WHO will also build close partnerships with various partners, including governments, non-governmental organizations and the private sector. Together, they will develop project plans, monitor project progress, and evaluate project effectiveness to ensure that every dollar is used for maximum value.
It is worth mentioning that the establishment of this financing platform is not overnight. Over the past few years, WHO has been actively advocating and advancing the cause of primary health care worldwide. They continue to raise global awareness and understanding of the importance of primary health care by organizing international conferences, publishing research reports, and conducting technical training. At the same time, they also actively seek cooperation opportunities with multilateral development banks and other financial institutions to jointly explore innovative financing models and cooperation mechanisms.
According to statistics, millions of people die every year due to lack of basic medical services. This alarming figure also makes us more deeply aware of the urgency and importance of strengthening the construction of primary health care system. The US $1.5 billion financing platform agreement signed by WHO and multilateral development banks has undoubtedly injected new impetus and vitality into the development of global primary health care.
Looking for chemical products? Let suppliers reach out to you!
2026-06-27
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
NHU and Sinopec Advance Liquid Methionine Project
-
Wall Street Predicts New Obesity Pills Will Be Priced Near $1000 Like Wegovy and Zepbound Supply and Competition Pressures Mount
-
Glenmark Targets 10–15 Percent CAGR in India by Shifting to High-Margin Drugs AbbVie Deal and New Launches Boost Outlook
-
Haryana’s Drug Crackdown Gets Massive Public Support State Launches Podcast to Boost Community Involvement
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
Recommend Reading
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Hengrui Strikes $500 Million Global Drug Deal with GSK Potential Payouts Up to $12 Billion
-
Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
-
Ascorbyl Palmitate: Properties, Uses, and Benefits
-
Premium Global Chemical Sourcing Requests (07-10May, 2026)
-
Supply Contraction Meets Weak Consumption—PCs Consolidate in Early May
-
Polyethylene Has Risen Strongly Since January
-
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou